Recent bioinformatics study has demonstrated that E2F targets and MYC targets V1, which are the number of cell proliferation-related pathways, can serve as the predictive biomarker for pancreatic cancer (Oshi et al., 2021). This evidence concerns the gene MYC and familial pancreatic carcinoma.